These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 10216501

  • 1. Clinical evaluation of serum and immunohistochemical expression of SCC and CA19-9 in radiation therapy for cervical cancer.
    Abe A, Nakano T, Morita S, Oka K.
    Anticancer Res; 1999; 19(1B):829-36. PubMed ID: 10216501
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Kim YB, Kim GE, Pyo HR, Cho NH, Keum KC, Lee CG, Seong J, Suh CO, Park TK.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):822-9. PubMed ID: 15465199
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of clinical behaviors and responses to radiation between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas of the cervix.
    Hong JH, Tsai CS, Wang CC, Lai CH, Chen WC, Lee SP, Chang TC, Tseng CJ.
    Chang Gung Med J; 2000 Jul 01; 23(7):396-404. PubMed ID: 10974754
    [Abstract] [Full Text] [Related]

  • 9. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A, Tana R, Cosio S, Genazzani AR.
    Crit Rev Oncol Hematol; 2008 Apr 01; 66(1):10-20. PubMed ID: 17964182
    [Abstract] [Full Text] [Related]

  • 10. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix.
    Ohno T, Nakayama Y, Nakamoto S, Kato S, Imai R, Nonaka T, Ishikawa H, Harashima K, Suzuki Y.
    Cancer; 2003 Jun 15; 97(12):3114-20. PubMed ID: 12784349
    [Abstract] [Full Text] [Related]

  • 11. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
    Zeng L.
    Zhonghua Wai Ke Za Zhi; 1993 Mar 15; 31(3):143-5. PubMed ID: 8223022
    [Abstract] [Full Text] [Related]

  • 12. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix.
    Ngan HY, Cheng GT, Yeung WS, Wong LC, Ma HK.
    Gynecol Oncol; 1994 Jan 15; 52(1):63-8. PubMed ID: 8307503
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
    Suzuki Y, Nakano T, Kato S, Ohno T, Tsujii H, Oka K.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):231-6. PubMed ID: 15337561
    [Abstract] [Full Text] [Related]

  • 14. [Bax and Bcl-2 expression predict response to radiotherapy in human cervical cancer].
    Harima Y, Oka A, Nagata K, Harima K, Tanaka Y, Shikata N.
    Gan To Kagaku Ryoho; 1998 Jul 01; 25(9):1273-7. PubMed ID: 9703806
    [Abstract] [Full Text] [Related]

  • 15. [Experiences with the squamous cell carcinoma antigen, a new tumor marker for cancer of the uterine cervix].
    Meier W, Eiermann W, Stieber P, Fateh-Moghadam A, Hepp H.
    Geburtshilfe Frauenheilkd; 1989 Jul 01; 49(7):625-9. PubMed ID: 2777050
    [Abstract] [Full Text] [Related]

  • 16. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
    Reesink-Peters N, van der Velden J, Ten Hoor KA, Boezen HM, de Vries EG, Schilthuis MS, Mourits MJ, Nijman HW, Aalders JG, Hollema H, Pras E, Duk JM, van der Zee AG.
    J Clin Oncol; 2005 Mar 01; 23(7):1455-62. PubMed ID: 15735121
    [Abstract] [Full Text] [Related]

  • 17. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labeling indices.
    Oka K, Nakano T, Hoshi T.
    Cancer; 1996 Jun 01; 77(11):2280-5. PubMed ID: 8635096
    [Abstract] [Full Text] [Related]

  • 18. Cancer of the uterine cervix: clinical value of squamous cell carcinoma antigen (SCC) measurements.
    Lozza L, Merola M, Fontanelli R, Stefanon B, Seregni E, Bombardieri E, De Palo G.
    Anticancer Res; 1997 Jun 01; 17(1B):525-9. PubMed ID: 9066575
    [Abstract] [Full Text] [Related]

  • 19. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma.
    Eifel PJ, Burke TW, Morris M, Smith TL.
    Gynecol Oncol; 1995 Oct 01; 59(1):38-44. PubMed ID: 7557613
    [Abstract] [Full Text] [Related]

  • 20. Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC).
    Hung YC, Shiau YC, Chang WC, Kao CH, Lin CC.
    Neoplasma; 2002 Oct 01; 49(6):415-7. PubMed ID: 12584591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.